Literature DB >> 15261942

The incremental prognostic value of percentage of heart rate reserve achieved over myocardial perfusion single-photon emission computed tomography in the prediction of cardiac death and all-cause mortality: superiority over 85% of maximal age-predicted heart rate.

Babak Azarbal1, Sean W Hayes, Howard C Lewin, Rory Hachamovitch, Ishac Cohen, Daniel S Berman.   

Abstract

OBJECTIVES: We sought to determine whether chronotropic incompetence (CI) adds incremental value in predicting cardiac death (CD) and all-cause mortality and to determine which marker of CI is superior.
BACKGROUND: Chronotropic incompetence, defined by either a low percent heart rate (HR) reserve achieved or failure to achieve 85% maximal age-predicted heart rate (MA-PHR), is a predictor of mortality. These variables have not been examined together in a comprehensive myocardial perfusion single-photon emission computed tomographic (SPECT), or MPS, model.
METHODS: A total of 10,021 patients who underwent exercise MPS, evaluated by a summed stress score (SSS), were followed up for 719 +/- 252 days. Percent HR reserve = (peak HR - rest HR)/(220 - age - rest HR) x 100, with <80% considered abnormal.
RESULTS: A total of 2,956 patients (29.5%) had low %HR reserve; 1,331 (13.3%) achieved <85% MA-PHR; and 1,296 (13.0%) had both. There were 234 deaths (93 CDs). On multivariate analysis, the SSS, %HR reserve, and inability to achieve 85% MA-PHR were predictors of all-cause mortality and CD (all p < 0.01). Myocardial perfusion SPECT was the most powerful predictor of CD (chi-square = 50). When the %HR reserve and ability to achieve 85% MA-PHR were considered, only the former remained a predictor of CD (p = 0.006 vs. p = 0.59).
CONCLUSIONS: In a comprehensive MPS model, CI was an important predictor of CD and all-cause mortality. Percent HR reserve was superior to the ability to achieve 85% MA-PHR in predicting CD; MPS was superior to both. Combined with previous studies, the findings suggest that %HR reserve should become the standard for assessing the adequacy of HR response during exercise testing, and that it should be routinely incorporated in risk stratification algorithms.

Entities:  

Mesh:

Year:  2004        PMID: 15261942     DOI: 10.1016/j.jacc.2004.02.060

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  43 in total

Review 1.  Peptide synthesis through evolution.

Authors:  K Tamura; R W Alexander
Journal:  Cell Mol Life Sci       Date:  2004-06       Impact factor: 9.261

Review 2.  [Complications during exercise testing].

Authors:  R Berent; J Auer; S P von Duvillard; H Sinzinger; P Schmid
Journal:  Herz       Date:  2011-11-17       Impact factor: 1.443

Review 3.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

4.  Heart rate response to regadenoson: Making the case for its value in clinical practice.

Authors:  Efstathia Andrikopoulou; Fadi G Hage
Journal:  J Nucl Cardiol       Date:  2015-08-27       Impact factor: 5.952

5.  Chronic heart failure, chronotropic incompetence, and the effects of beta blockade.

Authors:  K K A Witte; J G F Cleland; A L Clark
Journal:  Heart       Date:  2005-09-13       Impact factor: 5.994

6.  Why does the heart rate response to exercise predict adverse cardiac events?

Authors:  H C Routledge; J N Townend
Journal:  Heart       Date:  2005-12-30       Impact factor: 5.994

Review 7.  Non-invasive risk stratification: prognostic implications of exercise testing.

Authors:  C W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2007-03

8.  Underestimation of extent of ischemia by gated SPECT myocardial perfusion imaging in patients with left main coronary artery disease.

Authors:  Daniel S Berman; Xingping Kang; Piotr J Slomka; James Gerlach; Ling de Yang; Sean W Hayes; John D Friedman; Louise E J Thomson; Guido Germano
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

9.  Chronotropic incompetence as a risk predictor in children and young adults with catecholaminergic polymorphic ventricular tachycardia.

Authors:  Sonia Franciosi; Thomas M Roston; Frances K G Perry; Bjorn C Knollmann; Prince J Kannankeril; Shubhayan Sanatani
Journal:  J Cardiovasc Electrophysiol       Date:  2019-07-11

10.  Exercise outcomes in prevalent users of stimulant medications.

Authors:  Arthur N Westover; Paul A Nakonezny; Carolyn E Barlow; Wanpen Vongpatanasin; Bryon Adinoff; E Sherwood Brown; Eric M Mortensen; Ethan A Halm; Laura F DeFina
Journal:  J Psychiatr Res       Date:  2015-03-21       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.